{"schema_version":"1","generated_at":"2026-11-21T17:44:05.756Z","data_as_of":null,"url":"https://www.findmykol.com/kol/lydia-gedmintas","json_url":"https://www.findmykol.com/kol/lydia-gedmintas/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"lydia-gedmintas","name":"Lydia Gedmintas","credential":"MD","specialty":"Rheumatology","specialty_raw":"Rheumatology","therapeutic_area":"Rheumatology/Immunology","therapeutic_areas":["Rheumatology/Immunology"],"institution":"Brigham and Women's Hospital","institution_url":"https://www.findmykol.com/institution/brigham-and-women-s-hospital","city":"Boston","state":"MA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"on_file":["npi","openalex"],"values":"Shown on the profile page to a signed-in account."},"summary":"Lydia Gedmintas is a Rheumatology/Immunology physician affiliated with Brigham and Women's Hospital. OpenAlex indexes 18 publications with 1,265 citations (h-index 12).","overview":null,"focus":{"indications":[],"research_topics":["Rheumatology/Immunology"]},"scholarship":{"works_count":18,"cited_by_count":1265,"h_index":12,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":1,"shown":1,"withheld":0,"rows":[{"payer":"Sandoz Inc.","program_year":2023,"amount_usd":17.72,"payment_count":1}],"source":"payments"},"prescribing":{"data_year":2023,"areas_total":8,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":34.3,"classes_total":5,"classes":[{"class":"Folate Analog Metabolic Inhibitor","setting":"prescribed","share_pct":14.4,"drugs":[{"name":"Methotrexate","share_pct":100}],"max_beneficiaries":34},{"class":"TNF inhibitor","setting":"prescribed","share_pct":10.7,"drugs":[{"name":"Enbrel Sureclick","share_pct":44.1},{"name":"Humira(Cf) Pen","share_pct":40.9},{"name":"Humira Pen","share_pct":15.1}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":22.3,"classes_total":2,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":21,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":46},{"class":"Antidiarrheal microorganisms","setting":"prescribed","share_pct":1.3,"drugs":[{"name":"Folic Acid","share_pct":100}],"max_beneficiaries":null}]},{"area":"Nervous system","share_pct":17.1,"classes_total":4,"classes":[{"class":"Nonsteroidal Anti-inflammatory Drug","setting":"prescribed","share_pct":7.3,"drugs":[{"name":"Meloxicam","share_pct":81},{"name":"Ibuprofen","share_pct":19}],"max_beneficiaries":null},{"class":"Gabapentinoids","setting":"prescribed","share_pct":4.3,"drugs":[{"name":"Gabapentin","share_pct":67.6},{"name":"Pregabalin","share_pct":32.4}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2023,"office_pct":63,"facility_pct":37},"source":"medicare"},"publications":{"total":18,"shown":5,"withheld":13,"matched_by":"OpenAlex author record","recent":[{"title":"Implementation of a heat alert system for clinical staff in an ambulatory setting: A pilot project","year":2025,"journal":"The Journal of Climate Change and Health","source_url":"https://doi.org/10.1016/j.joclim.2025.100478","status":"verified"},{"title":"Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis","year":2023,"journal":"Annals of the Rheumatic Diseases","source_url":"https://doi.org/10.1136/ard-2023-223885","status":"verified"},{"title":"Mortality and immune-related adverse events after immune checkpoint inhibitor initiation for cancer among patients with pre-existing rheumatoid arthritis: a retrospective, comparative, cohort study","year":2023,"journal":"The Lancet Rheumatology","source_url":"https://doi.org/10.1016/s2665-9913(23)00064-4","status":"verified"},{"title":"Immunomodulator use, risk factors and management of flares, and mortality for patients with pre-existing rheumatoid arthritis after immune checkpoint inhibitors for cancer","year":2023,"journal":"Seminars in Arthritis and Rheumatism","source_url":"https://doi.org/10.1016/j.semarthrit.2023.152335","status":"verified"},{"title":"OP0029 COMPARATIVE SAFETY AND EFFECTIVENESS OF TNF INHIBITORS, IL6R INHIBITORS AND METHOTREXATE FOR THE TREATMENT OF IMMUNE CHECKPOINT INHIBITOR ASSOCIATED ARTHRITIS","year":2023,"journal":"Annals of the Rheumatic Diseases","source_url":"https://doi.org/10.1136/annrheumdis-2023-eular.556","status":"verified"}],"source":"works"},"similar":[{"name":"Paul Ridker","slug":"paul-ridker","institution":"Brigham and Women's Hospital","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/paul-ridker","json_url":"https://www.findmykol.com/kol/paul-ridker/profile.json"},{"name":"Scott Solomon","slug":"scott-solomon","institution":"Brigham and Women's Hospital","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/scott-solomon","json_url":"https://www.findmykol.com/kol/scott-solomon/profile.json"},{"name":"Marc Pfeffer","slug":"marc-pfeffer","institution":"Brigham and Women's Hospital","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/marc-pfeffer","json_url":"https://www.findmykol.com/kol/marc-pfeffer/profile.json"},{"name":"Reisa Sperling","slug":"reisa-sperling","institution":"Brigham and Women's Hospital","specialty":"Neurology","url":"https://www.findmykol.com/kol/reisa-sperling","json_url":"https://www.findmykol.com/kol/reisa-sperling/profile.json"},{"name":"David Felson","slug":"david-felson","institution":"Boston University","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/david-felson","json_url":"https://www.findmykol.com/kol/david-felson/profile.json"},{"name":"Marc Hochberg","slug":"marc-hochberg","institution":"University of Maryland School of Medicine","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/marc-hochberg","json_url":"https://www.findmykol.com/kol/marc-hochberg/profile.json"},{"name":"Philip Mease","slug":"philip-mease","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/philip-mease","json_url":"https://www.findmykol.com/kol/philip-mease/profile.json"},{"name":"Michelle Petri","slug":"michelle-petri","institution":"Johns Hopkins University School of Medicine","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/michelle-petri","json_url":"https://www.findmykol.com/kol/michelle-petri/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":13}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023}},"methodology_url":"https://www.findmykol.com/about#methodology"}